Oramed Pharmaceuticals Inc. (ORMP) earnings
ORMP earnings moved a median of +0.23% by the close. Quarterly and annual ORMP reports and results, each read against the price at its own news timestamp. Back to the ORMP overview →
14 measured ORMP earnings events.
Where these ORMP earnings landedvs 14 measured ORMP earnings reactions
| Middle 50% of ORMP earnings reactions | -2.23% to +1.03% |
|---|---|
| Median reaction (to close) | +0.23% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 ORMP earnings events with a measured close landed between -2.23% and +1.03%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ORAMED PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +1.43% | +0.95% | |
| Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -1.17% | +0.47% | |
| Form NT 10-Q ORAMED PHARMACEUTICALS For: Mar 31 | SEC filing · Form NT | +0.86% | -7.34% | |
| Form 10-K ORAMED PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +2.13% | +0.61% | |
| Oramed Reports Fiscal Third Quarter 2025 Financial Results | Press release | +0.22% | +1.74% | |
| Form 10-Q ORAMED PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +4.25% | +4.00% | |
| Form 10-K/A ORAMED PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.91% | -2.27% | |
| Form 10-K ORAMED PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.74% | |
| Form 10-Q ORAMED PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.12% | |
| Form 10-Q ORAMED PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -2.11% | -2.08% | |
| Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.05% | |
| Form 10-K ORAMED PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +1.07% | +2.14% | |
| Form 10-Q ORAMED PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.54% |
Keep exploring
More ORMP: analyst actions → · SEC filings → · ORMP overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BeyondSpring, Inc. - Ordinary Shares (BYSI) | 146 | 0.00% | 49% |
| Clearside Biomedical, Inc. (CLSD) | 145 | 0.00% | 46% |
| GlycoMimetics, Inc. (GLYC) | 144 | +0.53% | 54% |
| Mustang Bio, Inc. (MBIO) | 144 | -0.46% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.